Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemolytic Risk of Primaquine in G6PD Heterozygous Females
NCT03337152Phase 4Terminated
- Sponsor
- PATH
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of primaquine in malaria, sponsored by PATH. Started May 2018; status: terminated.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03337152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03337152.